Generated: August 18, 2017
DrugPatentWatch Database Preview
VUMON Drug Profile
Which patents cover Vumon, and when can generic versions of Vumon launch?
is a drug marketed by Hq Speclt Pharma and is included in one NDA.
The generic ingredient in VUMON is teniposide. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the teniposide profile page.
Summary for Tradename: VUMON
Pharmacology for Tradename: VUMON
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.